Tasly Pharmaceutical Group Co Ltd (600535) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.044x

Based on the latest financial reports, Tasly Pharmaceutical Group Co Ltd (600535) has a cash flow conversion efficiency ratio of 0.044x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥552.13 Million ≈ $80.79 Million USD) by net assets (CN¥12.55 Billion ≈ $1.84 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Tasly Pharmaceutical Group Co Ltd - Cash Flow Conversion Efficiency Trend (2001–2025)

This chart illustrates how Tasly Pharmaceutical Group Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read 600535 total debt and obligations for a breakdown of total debt and financial obligations.

Tasly Pharmaceutical Group Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Tasly Pharmaceutical Group Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Bread Financial Holdings, Inc. NYSE:BFH	0.171x
TELEPERFORMANCE SE ADR F:RCF0	N/A
Denison Mines Corp TO:DML	-0.049x
CIA EN.GER. ADR 1 F:CIDS	-0.059x
Shanghai M&G Stationery Inc SHG:603899	0.080x
International Game Technology PLC NYSE:IGT	0.154x
PVH Corp NYSE:PVH	0.020x
Steadfast Group Ltd AU:SDF	0.076x

Annual Cash Flow Conversion Efficiency for Tasly Pharmaceutical Group Co Ltd (2001–2025)

The table below shows the annual cash flow conversion efficiency of Tasly Pharmaceutical Group Co Ltd from 2001 to 2025. For the full company profile with market capitalisation and key ratios, see 600535 market cap overview.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥12.55 Billion ≈ $1.84 Billion	CN¥1.42 Billion ≈ $208.49 Million	0.114x	-31.74%
2024-12-31	CN¥12.11 Billion ≈ $1.77 Billion	CN¥2.01 Billion ≈ $294.79 Million	0.166x	-18.05%
2023-12-31	CN¥12.69 Billion ≈ $1.86 Billion	CN¥2.58 Billion ≈ $376.90 Million	0.203x	+12.19%
2022-12-31	CN¥12.63 Billion ≈ $1.85 Billion	CN¥2.29 Billion ≈ $334.39 Million	0.181x	-14.01%
2021-12-31	CN¥13.31 Billion ≈ $1.95 Billion	CN¥2.80 Billion ≈ $409.90 Million	0.210x	+45.47%
2020-12-31	CN¥12.38 Billion ≈ $1.81 Billion	CN¥1.79 Billion ≈ $262.10 Million	0.145x	+2.12%
2019-12-31	CN¥11.86 Billion ≈ $1.74 Billion	CN¥1.68 Billion ≈ $245.86 Million	0.142x	+6.27%
2018-12-31	CN¥11.21 Billion ≈ $1.64 Billion	CN¥1.49 Billion ≈ $218.59 Million	0.133x	+245.41%
2017-12-31	CN¥8.97 Billion ≈ $1.31 Billion	CN¥-822.56 Million ≈ $-120.37 Million	-0.092x	-165.20%
2016-12-31	CN¥8.21 Billion ≈ $1.20 Billion	CN¥1.15 Billion ≈ $168.83 Million	0.141x	+218.67%
2015-12-31	CN¥7.71 Billion ≈ $1.13 Billion	CN¥340.00 Million ≈ $49.75 Million	0.044x	-63.75%
2014-12-31	CN¥5.07 Billion ≈ $741.67 Million	CN¥616.76 Million ≈ $90.25 Million	0.122x	+45.65%
2013-12-31	CN¥4.14 Billion ≈ $606.32 Million	CN¥346.17 Million ≈ $50.66 Million	0.084x	-14.97%
2012-12-31	CN¥4.21 Billion ≈ $615.55 Million	CN¥413.31 Million ≈ $60.48 Million	0.098x	+174.55%
2011-12-31	CN¥3.78 Billion ≈ $552.55 Million	CN¥135.14 Million ≈ $19.77 Million	0.036x	-68.97%
2010-12-31	CN¥3.42 Billion ≈ $501.18 Million	CN¥395.05 Million ≈ $57.81 Million	0.115x	-37.45%
2009-12-31	CN¥2.17 Billion ≈ $317.70 Million	CN¥400.39 Million ≈ $58.59 Million	0.184x	+48.33%
2008-12-31	CN¥2.09 Billion ≈ $306.26 Million	CN¥260.21 Million ≈ $38.08 Million	0.124x	+10.81%
2007-12-31	CN¥1.97 Billion ≈ $288.96 Million	CN¥221.55 Million ≈ $32.42 Million	0.112x	+37.29%
2006-12-31	CN¥1.72 Billion ≈ $251.70 Million	CN¥140.56 Million ≈ $20.57 Million	0.082x	-40.49%
2005-12-31	CN¥1.56 Billion ≈ $229.00 Million	CN¥214.90 Million ≈ $31.45 Million	0.137x	-7.13%
2004-12-31	CN¥1.37 Billion ≈ $201.15 Million	CN¥203.27 Million ≈ $29.74 Million	0.148x	+201.11%
2003-12-31	CN¥1.20 Billion ≈ $175.82 Million	CN¥59.00 Million ≈ $8.63 Million	0.049x	-76.26%
2002-12-31	CN¥997.00 Million ≈ $145.89 Million	CN¥206.22 Million ≈ $30.18 Million	0.207x	-38.96%
2001-12-31	CN¥247.20 Million ≈ $36.17 Million	CN¥83.77 Million ≈ $12.26 Million	0.339x	--

About Tasly Pharmaceutical Group Co Ltd

SHG:600535 China Drug Manufacturers - Specialty & Generic

Market Cap

$3.31 Billion

CN¥22.60 Billion CNY

Market Cap Rank

#4645 Global

#855 in China

Share Price

CN¥15.13

Change (1 day)

-0.39%

52-Week Range

CN¥13.52 - CN¥17.41

All Time High

CN¥29.37